This proposal is to develop advanced statistical methods for analyzing large next generation sequencing data in genetic cancer epidemiological studies. The genomic era provides an unprecedented promise of understanding multifactorial diseases, such as cancer, and of identifying specific targets that can be used to develop patient-tailored therapies. Although hundreds of genome-wide association studies in the last few years have identified over a thousand common genetic variants associated with many complex diseases, these variants only explain a small fraction of heritability of diseases. The recent advance of next generation sequencing technologies provides an exciting new opportunity for discovering genes and biomarkers associated with diseases or traits, studying gene-environment interactions, predicting disease risk, and advancing personalized medicine. However, large sequencing data, especially rare variants, present fundamental statistical and computational challenges in data analysis and result interpretation. A shortage of appropriate and powerful statistical methods for analysis of next generation sequencing data has become a bottleneck for effectively using these rich resources to rapidly develop novel molecular cancer prevention and treatment strategies. The purpose ofthis proposal is to respond to this need. The proposed methods are motivated by and applied to the Harvard Lung Cancer and Breast Cancer exome and targeted sequencing association studies, in which the investigators play a major leadership role.
The specific aims are: (1) To develop a unified, powerful and robust statistical framework to test the association between rare variants and diseases and traits in sequencing association studies;(2) To develop penalized likelihood-based methods for risk prediction in population based sequencing studies;(3) To use the causal inference framework for mediation analysis to estimate and test for the direct effects of genetic rare variants and their indirect effects mediated through environmental risk factors on disease risk in sequencing studies;and account for measurement error in exposures. (4) To develop efficient user-friendly open access statistical software. This project integrates closely with Projects 1 and 2 with a common theme of analysis of large and complex observational study data, and takes advantage ofthe expertise of Projects 1 and 2 in causal inference on mediation analysis and modeling environmental exposures in studying the interplay of genes and environment. It also relies heavily on the Statistical Computing Core, and the organizational infrastructure, team'building strategies, workshops and visitor program provided through the Administrative Core.

Public Health Relevance

This project aims to develop statistical methods to advance cancer prevention and intervention strategies by using next generation sequencing data to identify genetic variants associated with cancer, to build genetic risk prediction models for cancer risk;and to study the direct and indirect effects of genetic variants in the interplay of genes and environment in cancer risk and progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA134294-06
Application #
8589661
Study Section
Special Emphasis Panel (ZCA1-RPRB-2 (M1))
Project Start
2008-09-10
Project End
2018-06-30
Budget Start
2013-09-05
Budget End
2014-06-30
Support Year
6
Fiscal Year
2013
Total Cost
$142,821
Indirect Cost
$54,387
Name
Harvard University
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Bind, M-A C; Vanderweele, T J; Coull, B A et al. (2016) Causal mediation analysis for longitudinal data with exogenous exposure. Biostatistics 17:122-34
Hernán, Miguel A; Robins, James M (2016) Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am J Epidemiol :
Chen, Jun; Just, Allan C; Schwartz, Joel et al. (2016) CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies. Bioinformatics 32:469-71
Lin, Xinyi; Lee, Seunggeun; Wu, Michael C et al. (2016) Test for rare variants by environment interactions in sequencing association studies. Biometrics 72:156-64
Lee, Kyu Ha; Tadesse, Mahlet G; Baccarelli, Andrea A et al. (2016) Multivariate Bayesian variable selection exploiting dependence structure among outcomes: Application to air pollution effects on DNA methylation. Biometrics :
Yung, Godwin; Lin, Xihong (2016) Validity of using ad hoc methods to analyze secondary traits in case-control association studies. Genet Epidemiol 40:732-743
Arvold, Nils D; Cefalu, Matthew; Wang, Yun et al. (2016) Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma. J Neurooncol :
Wasfy, Jason H; Dominici, Francesca; Yeh, Robert W (2016) Letter by Wasfy et al Regarding Article, ""Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Re Circulation 133:e376
Carere, Deanna Alexis; Kraft, Peter; Kaphingst, Kimberly A et al. (2016) Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing. Genet Med 18:65-72
Zigler, Corwin Matthew (2016) The Central Role of Bayes' Theorem for Joint Estimation of Causal Effects and Propensity Scores. Am Stat 70:47-54

Showing the most recent 10 out of 136 publications